{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:23:55Z","timestamp":1792614235436,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF18CC0034900"],"award-info":[{"award-number":["NNF18CC0034900"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R190-2014-3904"],"award-info":[{"award-number":["R190-2014-3904"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["8045-00091B"],"award-info":[{"award-number":["8045-00091B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK124238"],"award-info":[{"award-number":["R01 DK124238"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74038-4","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T09:06:27Z","timestamp":1780995987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Semaglutide attenuates neuroinflammation in male mice"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6095-4891","authenticated-orcid":false,"given":"Dylan M.","family":"Belmont-Rausch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7814-3859","authenticated-orcid":false,"given":"Mette Q.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie A.","family":"Bentsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine N.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6276-5389","authenticated-orcid":false,"given":"Anna","family":"Secher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6173-8879","authenticated-orcid":false,"given":"Jaime","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0614-0373","authenticated-orcid":false,"given":"Vivek","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2781-1594","authenticated-orcid":false,"given":"Kristoffer L.","family":"Egerod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1831-6746","authenticated-orcid":false,"given":"Anne-Mette","family":"Bjerregaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer","family":"Niss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2873-7974","authenticated-orcid":false,"given":"Sarah","family":"Bau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Pyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Dalgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrte","family":"Merkestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Wichern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Thim","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Polex-Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2439-7116","authenticated-orcid":false,"given":"Lotte Bjerre","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0207-4831","authenticated-orcid":false,"given":"Tune H.","family":"Pers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"74038_CR1","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr.","year":"2024","unstructured":"Jack, C. R. Jr. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimer\u2019s. Dement. 20, 5143\u20135169 (2024).","journal-title":"Alzheimer\u2019s. Dement."},{"key":"74038_CR2","doi-asserted-by":"publisher","unstructured":"Bieger, A. et al. Neuroinflammation biomarkers in the AT(N) framework across the Alzheimer\u2019s disease continuum. J. Prev. Alzheimers Dis. https:\/\/doi.org\/10.14283\/jpad.2023.54 (2023).","DOI":"10.14283\/jpad.2023.54"},{"key":"74038_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat. Genet. 51, 414\u2013430 (2019).","journal-title":"Nat. Genet."},{"key":"74038_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat. Genet. 54, 412\u2013436 (2022).","journal-title":"Nat. Genet."},{"key":"74038_CR5","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbadis.2016.04.017","volume":"1863","author":"S Pugazhenthi","year":"2017","unstructured":"Pugazhenthi, S., Qin, L. & Reddy, P. H. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease. Biochim. Biophys. Acta 1863, 1037\u20131045 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"74038_CR6","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso, S. P. et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 375, 1834\u20131844 (2016).","journal-title":"N. Engl. J. Med."},{"key":"74038_CR7","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding, J. P. H. et al. Once-weekly semaglutide in adults with overweight or obesity. N. Engl. J. Med. 384, 989\u20131002 (2021).","journal-title":"N. Engl. J. Med."},{"key":"74038_CR8","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","volume":"389","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod, M. N. et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N. Engl. J. Med. 389, 1069\u20131084 (2023).","journal-title":"N. Engl. J. Med."},{"key":"74038_CR9","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm919","volume":"9","author":"MJ During","year":"2003","unstructured":"During, M. J. et al. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat. Med. 9, 1173\u20131179 (2003).","journal-title":"Nat. Med"},{"key":"74038_CR10","doi-asserted-by":"crossref","unstructured":"Bendotti, G. et al. The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists. Pharmacol. Res. 182, 106320 (2022).","DOI":"10.1016\/j.phrs.2022.106320"},{"key":"74038_CR11","doi-asserted-by":"publisher","first-page":"e12268","DOI":"10.1002\/trc2.12268","volume":"8","author":"CH N\u00f8rgaard","year":"2022","unstructured":"N\u00f8rgaard, C. H. et al. Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers. Alzheimer\u2019s. Dement. Transl. Res. Clin. Interv. 8, e12268 (2022).","journal-title":"Alzheimer\u2019s. Dement. Transl. Res. Clin. Interv."},{"key":"74038_CR12","doi-asserted-by":"crossref","unstructured":"Wium-Andersen, I. K., Osler, M., J\u00f8rgensen, M. B. & Rungby, J. Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case \u2013 control study. Eur. J. Endocrinol. 181, 499\u2013507 (2019).","DOI":"10.1530\/EJE-19-0259"},{"key":"74038_CR13","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.2337\/db23-1802-PUB","volume":"72","author":"T Wang","year":"2023","unstructured":"Wang, T., Buse, J. B., Pate, V. & St\u00fcrmer, T. -PUB: liraglutide as a potential drug repurposing candidate for Alzheimer\u2019s disease and related dementia\u2014real-world evidence. Diabetes 72, 1802\u20131 (2023).","journal-title":"Diabetes"},{"key":"74038_CR14","doi-asserted-by":"crossref","unstructured":"Wang, W. et al. Associations of semaglutide with first-time diagnosis of Alzheimer\u2019s disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US. Alzheimers Dement. 20, 8661\u20138672 (2024).","DOI":"10.1002\/alz.14313"},{"key":"74038_CR15","doi-asserted-by":"crossref","unstructured":"Cummings, J. L. et al. Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials. Lancet 407, 2167\u20132179 (2026).","DOI":"10.1016\/S0140-6736(26)00459-9"},{"key":"74038_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun, S. P. et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat. Med. 24, 931\u2013938 (2018).","journal-title":"Nat. Med."},{"key":"74038_CR17","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41591-018-0109-4","volume":"24","author":"L Brundin","year":"2018","unstructured":"Brundin, L., Bergkvist, L. & Brundin, P. Fire prevention in the Parkinson\u2019s disease brain. Nat. Med. 24, 900\u2013902 (2018).","journal-title":"Nat. Med"},{"key":"74038_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40478-021-01180-z","volume":"9","author":"J-S Park","year":"2021","unstructured":"Park, J.-S. et al. Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer\u2019s disease. Acta Neuropathol. Commun. 9, 78 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"74038_CR19","doi-asserted-by":"publisher","unstructured":"Li, Z. et al. Systemic GLP-1R agonist treatment reverses mouse glial and neurovascular cell transcriptomic aging signatures in a genome-wide manner. Commun. Biol. 1\u20136. https:\/\/doi.org\/10.1038\/s42003-021-02208-9 (2021).","DOI":"10.1038\/s42003-021-02208-9"},{"key":"74038_CR20","doi-asserted-by":"crossref","unstructured":"Wang, L. et al. Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazole-kindled mice. Int. J. Mol. Med. 48, 219 (2021).","DOI":"10.3892\/ijmm.2021.5052"},{"key":"74038_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jacbts.2018.09.004","volume":"3","author":"G Rakipovski","year":"2018","unstructured":"Rakipovski, G. et al. The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE\u2212\/\u2212 and LDLr\u2212\/\u2212 mice by a mechanism that includes inflammatory pathways. JACC Basic Transl. Sci. 3, 844\u2013857 (2018).","journal-title":"JACC Basic Transl. Sci."},{"key":"74038_CR22","doi-asserted-by":"crossref","unstructured":"Coenraad, W. et al. The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF. JACC Basic Transl. Sci. 8, 1298\u20131314 (2023).","DOI":"10.1016\/j.jacbts.2023.05.012"},{"key":"74038_CR23","doi-asserted-by":"publisher","first-page":"109647","DOI":"10.1016\/j.intimp.2022.109647","volume":"115","author":"MA Sadek","year":"2023","unstructured":"Sadek, M. A., Kandil, E. A., El Sayed, N. S., Sayed, H. M. & Rabie, M. A. Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K\/Akt\/GSK-3\u03b2 pathway. Int. Immunopharmacol. 115, 109647 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"74038_CR24","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.62347\/IZGJ1332","volume":"16","author":"L Chen","year":"2024","unstructured":"Chen, L., Xu, H., Zhang, C., He, J. & Wang, Y. Semaglutide alleviates early brain injury following subarachnoid hemorrhage by suppressing ferroptosis and neuroinflammation via SIRT1 pathway. Am. J. Transl. Res. 16, 1102\u20131117 (2024).","journal-title":"Am. J. Transl. Res"},{"key":"74038_CR25","doi-asserted-by":"publisher","unstructured":"Zhao, L. et al. Pharmacologically reversible zonation-dependent endothelial cell transcriptomic changes with neurodegenerative disease associations in the aged brain. 1\u201315. https:\/\/doi.org\/10.1038\/s41467-020-18249-3 (2020).","DOI":"10.1038\/s41467-020-18249-3"},{"key":"74038_CR26","doi-asserted-by":"publisher","first-page":"943","DOI":"10.14336\/AD.2021.1029","volume":"13","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Blocking C3d+\/GFAP+A1 astrocyte conversion with semaglutide attenuates blood-brain barrier disruption in mice after ischemic stroke. Aging Dis. 13, 943\u2013959 (2022).","journal-title":"Aging Dis."},{"key":"74038_CR27","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1161\/STROKEAHA.121.037775","volume":"53","author":"WD Strain","year":"2022","unstructured":"Strain, W. D. et al. Effects of semaglutide on stroke subtypes in type 2 diabetes: Post Hoc analysis of the randomized SUSTAIN 6 and PIONEER 6. Stroke 53, 2749\u20132757 (2022).","journal-title":"Stroke"},{"key":"74038_CR28","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.2337\/dc19-0883","volume":"42","author":"HW Rodbard","year":"2019","unstructured":"Rodbard, H. W. et al. Oral semaglutide versus empagliflozin in patients with type 2 diabetes uncontrolled on metformin: the PIONEER 2 trial. Diabetes Care 42, 2272\u20132281 (2019).","journal-title":"Diabetes Care"},{"key":"74038_CR29","doi-asserted-by":"publisher","first-page":"101737","DOI":"10.1016\/j.eclinm.2022.101737","volume":"55","author":"S Verma","year":"2023","unstructured":"Verma, S. et al. Effects of once-weekly semaglutide 2.4\u2009mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials. EClinicalMedicine 55, 101737 (2023).","journal-title":"EClinicalMedicine"},{"key":"74038_CR30","doi-asserted-by":"crossref","unstructured":"Rode, A. K. O. et al. Induced human regulatory T cells express the glucagon-like peptide-1 receptor. Cells 11, 2587 (2022).","DOI":"10.3390\/cells11162587"},{"key":"74038_CR31","doi-asserted-by":"crossref","unstructured":"De Barra, C. et al. Glucagon-like peptide-1 therapy in people with obesity restores natural killer cell metabolism and effector function. Obesity 31, 1787\u20131797 (2023).","DOI":"10.1002\/oby.23772"},{"key":"74038_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","volume":"36","author":"CK Wong","year":"2024","unstructured":"Wong, C. K. et al. Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation. Cell Metab. 36, 130\u2013143.e5 (2024).","journal-title":"Cell Metab."},{"key":"74038_CR33","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41586-024-07469-y","volume":"630","author":"H Jin","year":"2024","unstructured":"Jin, H., Li, M., Jeong, E., Castro-Martinez, F. & Zuker, C. S. A body\u2013brain circuit that regulates body inflammatory responses. Nature 630, 695\u2013703 (2024).","journal-title":"Nature"},{"key":"74038_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 9, 559 (2008).","journal-title":"BMC Bioinform."},{"key":"74038_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neuron.2018.08.030","volume":"100","author":"L Duan","year":"2018","unstructured":"Duan, L. et al. PDGFRb cells rapidly relay inflammatory signal from the circulatory system to neurons via chemokine CCL2. Neuron 100, 183\u2013200.e8 (2018).","journal-title":"Neuron"},{"key":"74038_CR36","doi-asserted-by":"publisher","first-page":"102188","DOI":"10.1016\/j.coi.2022.102188","volume":"76","author":"DA Posner","year":"2022","unstructured":"Posner, D. A., Lee, C. Y. C., Portet, A. & Clatworthy, M. R. Humoral immunity at the brain borders in homeostasis. Curr. Opin. Immunol. 76, 102188 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"74038_CR37","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1016\/j.cell.2021.04.021","volume":"184","author":"Z Yao","year":"2021","unstructured":"Yao, Z. et al. A taxonomy of transcriptomic cell types across the isocortex and hippocampal formation. Cell 184, 3222\u20133241.e26 (2021).","journal-title":"Cell"},{"key":"74038_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41587-021-01033-z","volume":"40","author":"E Dann","year":"2022","unstructured":"Dann, E., Henderson, N. C., Teichmann, S. A., Morgan, M. D. & Marioni, J. C. Differential abundance testing on single-cell data using k-nearest neighbor graphs. Nat. Biotechnol. 40, 245\u2013253 (2022).","journal-title":"Nat. Biotechnol."},{"key":"74038_CR39","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","volume":"556","author":"A-C Wendeln","year":"2018","unstructured":"Wendeln, A.-C. et al. Innate immune memory in the brain shapes neurological disease hallmarks. Nature 556, 332\u2013338 (2018).","journal-title":"Nature"},{"key":"74038_CR40","doi-asserted-by":"crossref","unstructured":"Gabery, S. et al. Semaglutide lowers body weight in rodents via distributed neural pathways. JCI Insight 5, e133429 (2021).","DOI":"10.1172\/jci.insight.133429"},{"key":"74038_CR41","doi-asserted-by":"crossref","unstructured":"Ludwig, M. Q. et al. A genetic map of the mouse dorsal vagal complex and its role in obesity. Nat. Metab. 3, 530\u2013545 (2021).","DOI":"10.1038\/s42255-021-00363-1"},{"key":"74038_CR42","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41586-022-05161-7","volume":"609","author":"A Ilanges","year":"2022","unstructured":"Ilanges, A. et al. Brainstem ADCYAP1+ neurons control multiple aspects of sickness behaviour. Nature 609, 761\u2013771 (2022).","journal-title":"Nature"},{"key":"74038_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25525-3","volume":"12","author":"W Cheng","year":"2021","unstructured":"Cheng, W. et al. NTS Prlh overcomes orexigenic stimuli and ameliorates dietary and genetic forms of obesity. Nat. Commun. 12, 5175 (2021).","journal-title":"Nat. Commun."},{"key":"74038_CR44","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-023-06758-2","volume":"624","author":"T Ly","year":"2023","unstructured":"Ly, T. et al. Sequential appetite suppression by oral and visceral feedback to the brainstem. Nature 624, 130\u2013137 (2023).","journal-title":"Nature"},{"key":"74038_CR45","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"74038_CR46","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","volume":"15","author":"B Van de Sande","year":"2020","unstructured":"Van de Sande, B. et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat. Protoc. 15, 2247\u20132276 (2020).","journal-title":"Nat. Protoc."},{"key":"74038_CR47","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/alz.12389","volume":"18","author":"D Boche","year":"2022","unstructured":"Boche, D. & Gordon, M. N. Diversity of transcriptomic microglial phenotypes in aging and Alzheimer\u2019s disease. Alzheimer\u2019s. Dement. 18, 360\u2013376 (2022).","journal-title":"Alzheimer\u2019s. Dement."},{"key":"74038_CR48","doi-asserted-by":"crossref","unstructured":"G\u00f3mez Morillas, A., Besson, V. C. & Lerouet, D. Microglia and neuroinflammation: what place for P2RY12? Int. J. Mol. Sci. 22, 1636 (2021).","DOI":"10.3390\/ijms22041636"},{"key":"74038_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"74038_CR50","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1042\/BCJ20200511","volume":"478","author":"KA Young","year":"2021","unstructured":"Young, K. A., Biggins, L. & Sharpe, H. J. Protein tyrosine phosphatases in cell adhesion. Biochem. J. 478, 1061\u20131083 (2021).","journal-title":"Biochem. J."},{"key":"74038_CR51","doi-asserted-by":"publisher","unstructured":"Yang, A. C. et al. A human brain vascular atlas reveals diverse mediators of Alzheimer\u2019s risk. Nature. https:\/\/doi.org\/10.1038\/s41586-021-04369-3 (2022).","DOI":"10.1038\/s41586-021-04369-3"},{"key":"74038_CR52","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1016\/j.cell.2023.08.037","volume":"186","author":"N Sun","year":"2023","unstructured":"Sun, N. et al. Human microglial state dynamics in Alzheimer\u2019s disease progression. Cell 186, 4386\u20134403.e29 (2023).","journal-title":"Cell"},{"key":"74038_CR53","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41593-023-01334-3","volume":"26","author":"N Sun","year":"2023","unstructured":"Sun, N. et al. Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer\u2019s disease. Nat. Neurosci. 26, 970\u2013982 (2023).","journal-title":"Nat. Neurosci."},{"key":"74038_CR54","doi-asserted-by":"publisher","first-page":"e1004219","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"74038_CR55","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/s41588-022-01167-z","volume":"54","author":"MJ Zhang","year":"2022","unstructured":"Zhang, M. J. et al. Polygenic enrichment distinguishes disease associations of individual cells in single-cell RNA-seq data. Nat. Genet. 54, 1572\u20131580 (2022).","journal-title":"Nat. Genet."},{"key":"74038_CR56","doi-asserted-by":"publisher","unstructured":"Boles, J. S., Huarte, O. U. & Tansey, M. G. Microfluidics-free single-cell genomics reveals complex central-peripheral immune crosstalk in the mouse brain during peripheral inflammation. bioRxiv. https:\/\/doi.org\/10.1101\/2023.10.05.561054 (2023).","DOI":"10.1101\/2023.10.05.561054"},{"key":"74038_CR57","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2013","unstructured":"Liu, C.-C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106\u2013118 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"74038_CR58","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Garc\u00eda, V. A., Alameda, J. P., Page, A. & Casanova, M. L. Role of NF-\u03baB in ageing and age-related diseases: lessons from genetically modified mouse models. Cells 10, 1906 (2021).","DOI":"10.3390\/cells10081906"},{"key":"74038_CR59","doi-asserted-by":"crossref","unstructured":"Wright, R. Lysosome regulation of microglia in Alzheimer\u2019s disease via TFEB\u2013vacuolar ATPase. Nat. Neurosci. 27, 13\u201314 (2024).","DOI":"10.1038\/s41593-023-01495-1"},{"key":"74038_CR60","doi-asserted-by":"crossref","unstructured":"Neff, R. A. et al. Molecular subtyping of Alzheimer\u2019s disease using RNA sequencing data reveals novel mechanisms and targets. Sci. Adv. 7, eabb5398 (2021).","DOI":"10.1126\/sciadv.abb5398"},{"key":"74038_CR61","doi-asserted-by":"publisher","unstructured":"Gabitto, M. I. et al. Integrated multimodal cell atlas of Alzheimer\u2019s disease. Nat. Neurosci. https:\/\/doi.org\/10.1038\/s41593-024-01774-5 (2024).","DOI":"10.1038\/s41593-024-01774-5"},{"key":"74038_CR62","doi-asserted-by":"publisher","first-page":"e057848","DOI":"10.1002\/alz.057848","volume":"17","author":"P Edison","year":"2021","unstructured":"Edison, P. et al. Evaluation of liraglutide in the treatment of Alzheimer\u2019s disease. Alzheimer\u2019s. Dement. 17, e057848 (2021).","journal-title":"Alzheimer\u2019s. Dement."},{"key":"74038_CR63","doi-asserted-by":"crossref","unstructured":"Gejl, M. et al. In Alzheimer\u2019s disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial. Front. Aging Neurosci. 8, 108 (2016).","DOI":"10.3389\/fnagi.2016.00108"},{"key":"74038_CR64","doi-asserted-by":"crossref","unstructured":"Frederiksen, K. S. et al. Effects of semaglutide on alzheimer\u2019s disease-related biological processes: results from a biofluid biomarker and multiomics immunophenotyping phase 3 study in patients with early Alzheimer\u2019s disease after 12 weeks of treatment. https:\/\/sciencehub.novonordisk.com\/congresses\/ctad2025\/frederiksen.html (2025).","DOI":"10.1212\/WNL.0000000000216961"},{"key":"74038_CR65","doi-asserted-by":"publisher","first-page":"e650 LP","DOI":"10.1212\/WNL.0000000000200771","volume":"99","author":"B Tang","year":"2022","unstructured":"Tang, B. et al. Genetic variation in targets of antidiabetic drugs and Alzheimer disease risk. Neurology 99, e650 LP\u2013e650659 (2022).","journal-title":"Neurology"},{"key":"74038_CR66","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/dom.12884","volume":"19","author":"BJ von Scholten","year":"2017","unstructured":"von Scholten, B. J. et al. Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: a sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial. Diabetes Obes. Metab. 19, 901\u2013905 (2017).","journal-title":"Diabetes Obes. Metab."},{"key":"74038_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97967-0","volume":"11","author":"EH Zobel","year":"2021","unstructured":"Zobel, E. H. et al. Effect of liraglutide on expression of inflammatory genes in type 2 diabetes. Sci. Rep. 11, 18522 (2021).","journal-title":"Sci. Rep."},{"key":"74038_CR68","first-page":"1","volume":"1","author":"S Nizari","year":"2021","unstructured":"Nizari, S. et al. Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre) conditioning neuroprotection against ischaemic stroke. Basic Res. Cardiol. 1, 1\u201313 (2021).","journal-title":"Basic Res. Cardiol."},{"key":"74038_CR69","doi-asserted-by":"crossref","unstructured":"Ahtiluoto, S. et al. Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology 75, 1195\u20131202 (2010).","DOI":"10.1212\/WNL.0b013e3181f4d7f8"},{"key":"74038_CR70","doi-asserted-by":"crossref","unstructured":"Butterfield, D. A. & Halliwell, B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat. Rev. Neurosci. 20, 148\u2013160 (2019).","DOI":"10.1038\/s41583-019-0132-6"},{"key":"74038_CR71","doi-asserted-by":"crossref","unstructured":"Carranza-Naval, M. J. et al. Liraglutide reduces vascular damage, neuronal loss, and cognitive impairment in a mixed murine model of Alzheimer\u2019s disease and type 2 diabetes. Front. Aging Neurosci. 13, 741923 (2021).","DOI":"10.3389\/fnagi.2021.741923"},{"key":"74038_CR72","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.cmet.2024.09.003","volume":"36","author":"B Chen","year":"2024","unstructured":"Chen, B. et al. GLP-1 programs the neurovascular landscape. Cell Metab. 36, 2173\u20132189 (2024).","journal-title":"Cell Metab."},{"key":"74038_CR73","doi-asserted-by":"publisher","first-page":"eabq5923","DOI":"10.1126\/scitranslmed.abq5923","volume":"15","author":"YJ Sung","year":"2023","unstructured":"Sung, Y. J. et al. Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer\u2019s disease. Sci. Transl. Med. 15, eabq5923 (2023).","journal-title":"Sci. Transl. Med"},{"key":"74038_CR74","unstructured":"Illumina. bcl2fastq2 Software v2.19.1. Release Notes 1\u20133. https:\/\/emea.support.illumina.com\/content\/dam\/illumina-support\/documents\/downloads\/software\/bcl2fastq\/bcl2fastq-2-19-1-release-notes-1000000035330-00.pdf (2017)."},{"key":"74038_CR75","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"74038_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1670-y","volume":"20","author":"A Srivastava","year":"2019","unstructured":"Srivastava, A., Malik, L., Smith, T., Sudbery, I. & Patro, R. Alevin efficiently estimates accurate gene abundances from dscRNA-seq data. Genome Biol. 20, 65 (2019).","journal-title":"Genome Biol."},{"key":"74038_CR77","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e29 (2021).","journal-title":"Cell"},{"key":"74038_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1662-y","volume":"20","author":"ATL Lun","year":"2019","unstructured":"Lun, A. T. L. et al. EmptyDrops: distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data. Genome Biol. 20, 63 (2019).","journal-title":"Genome Biol."},{"key":"74038_CR79","doi-asserted-by":"crossref","unstructured":"Germain, P.-L., Lun, A., Meixide, C. G., Macnair, W. & Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. F1000Research 10, 979 (2022).","DOI":"10.12688\/f1000research.73600.2"},{"key":"74038_CR80","doi-asserted-by":"publisher","DOI":"10.1101\/2022.03.15.484475","author":"V Petukhov","year":"2022","unstructured":"Petukhov, V. et al. Case-control analysis of single-cell RNA-seq studies. bioRxiv https:\/\/doi.org\/10.1101\/2022.03.15.484475 (2022).","journal-title":"bioRxiv"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74038-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74038-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74038-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T23:12:12Z","timestamp":1785107532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74038-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74038"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74038-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"THP receives research support from the Novo Nordisk A\/S, his household\u00a0holds stocks in Novo Nordisk A\/S and he\u00a0has received counseling fees from Eli Lilly and Zealand Pharma. During completion of this study, DMR, MAB and MQL have become employed at Novo Nordisk A\/S; K.D. has become employed at the Lundbeck Foundation; and F.W. at Lundbeck A\/S. S.N.H., A.S., D.H., J.M., V.D., A.M.B., K.N., S.B., C.P., M.M., C.T.H., J.P.W., L.B.K. are employees at Novo Nordisk A\/S. All other authors have no competing interests to declare.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"During the preparation of this work the authors used generative AI tools to improve readability and language of the manuscript. After using these services, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":2,"name":"Ethics","label":"<b>Declaration of generative AI and AI-assisted technologies in the writing process<\/b>","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7328"}}